A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles
2011

New Method for Making Cancer Drug Nanoparticles

publication Evidence: moderate

Author Information

Author(s): Zu Yuangang, Wang Dan, Zhao Xiuhua, Jiang Ru, Zhang Qi, Zhao Dongmei, Li Yong, Zu Baishi, Sun Zhiqiang

Primary Institution: Northeast Forestry University

Hypothesis

The study aims to develop a targeted drug delivery system for cancer chemotherapy using folic acid conjugated dextran nanoparticles loaded with camptothecin.

Conclusion

The study successfully developed tumor-targeted nanoparticles with a mean particle size of 182.21 nm and demonstrated effective drug encapsulation and loading efficiencies.

Supporting Evidence

  • The mean particle size of the nanoparticles was optimized to 182.21 nm.
  • Drug encapsulation efficiency was found to be 62.13%.
  • Loading efficiency of the nanoparticles was 36.12%.

Takeaway

Researchers created tiny particles that can deliver a cancer drug directly to tumors, making it more effective and reducing side effects.

Methodology

The nanoparticles were prepared using a supercritical antisolvent technique and characterized using various methods including SEM, FT-IR, DSC, and XRD.

Digital Object Identifier (DOI)

10.3390/ijms12074237

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication